BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Recommendation of “Moderate Buy” by Brokerages
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the twenty-four analysts that are currently covering the stock, Marketbeat.com reports. Nine analysts have rated the stock with a hold recommendation and fifteen have given a buy recommendation to the company. The average 1-year target price among analysts […]
More Stories
US Personal Income Growth Accelerates in April, Surges 0.8 Percent
By Andrew Moran U.S. consumers earned more income, saved more money, and spent less in April, new U.S. government data...
House Megabill to Expand Health Savings Account Eligibility and Benefits
By Kevin Stocklin The One Big Beautiful Bill Act, passed by the House of Representatives on May 22 and currently...
Trump Envoy Rejects Hamas Response to Gaza Cease-Fire Proposal as ‘Totally Unacceptable’
By Tom Ozimek President Donald Trump’s special envoy to the Middle East has dismissed the Hamas response to a U.S.-backed...
Automotive Stocks To Watch Today – May 29th
NVIDIA, Tesla, and Salesforce are the three Automotive stocks to watch today, according to MarketBeat’s stock screener tool. Automotive stocks...
Automotive Stocks To Watch Today – May 29th
NVIDIA, Tesla, and Salesforce are the three Automotive stocks to watch today, according to MarketBeat’s stock screener tool. Automotive stocks...
Automotive Stocks To Watch Today – May 29th
NVIDIA, Tesla, and Salesforce are the three Automotive stocks to watch today, according to MarketBeat’s stock screener tool. Automotive stocks...